Why BioCardia (BCDA) Stock Is Falling Today BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering.
Why BioCardia (BCDA) Stock Is Up 95% Today BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday Pre-market stock movers are worth diving into on Monday and we have all of the latest news worth knowing about this morning!
What's Going with BioCardia Stock Friday? On Friday before the market open, BioCardia announced it received approval from the United States Patent Office for its application entitled, "Radial and Transendocardial Delivery Catheter."
BCDA Stock Earnings: BioCardia Misses EPS, Misses Revenue for Q2 2023 BCDA stock results show that BioCardia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2023.
BCDA Stock Earnings: BioCardia Beats EPS, Misses Revenue for Q4 2023 BCDA stock results show that BioCardia beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Earnings Scheduled For March 27, 2024 Companies Reporting Before The Bell • Local Bounti (
NYSE:LOCL ) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
